The West AustralianPerth researcher leads trial into AIDS vaccineThe West AustralianDr D'Orsogna, 35, won a European medical prize for his recent work in the Netherlands studying organ transplant rejection. He showed immune responses against transp…
Intensified Immunochemotherapy Benefits B-Cell Lymphoma – Doctors Lounge
ecancermedicalscienceIntensified Immunochemotherapy Benefits B-Cell LymphomaDoctors LoungeFor patients with untreated diffuse large B-cell lymphoma, intensified immunochemotherapy with rituximab, doxorubicin, cyclophosphamide, vindesine, bleomycin, and…
TBI: Not a Single Disease, but Many – Family Practice News Digital Network
Family Practice News Digital NetworkTBI: Not a Single Disease, but ManyFamily Practice News Digital NetworkDiffuse cerebral swelling, the most common cause of brain death following severe TBI in both adults and children, is 3.5 times more common in chi…
Intense Chemo Best for Aggressive Lymphoma – Medscape
ecancermedicalscienceIntense Chemo Best for Aggressive LymphomaMedscapeNovember 29, 2011 — Adding rituximab to a dose-intensive immunochemotherapy regimen significantly improves survival in young patients with diffuse large B cell lymphoma with low-i…
Bristol-Myers Squibb (BMY) Breaks Through Resistance at $31.30 – Financial News Network Online
Bristol-Myers Squibb (BMY) Breaks Through Resistance at $31.30Financial News Network OnlineThe Company's products and experimental therapies address cancer, heart disease, HIV/AIDS, diabetes, rheumatoid arthritis, hepatitis, organ transplant reject…
Man's plea to save his wife's life – Grantham Today
Man's plea to save his wife's lifeGrantham TodayHusband Paul Jenkins from Hertfordshire is urging people to join the stem cell transplant register after his wife was diagnosed with a type of blood cancer. Gilly Jenkins was diagnosed with Hodgki…
Stem cell transplant breakthrough 'may offer hope regarding epilepsy' – Epilepsy Research UK
Epilepsy Research UKStem cell transplant breakthrough 'may offer hope regarding epilepsy'Epilepsy Research UKA new breakthrough regarding stem cell transplants could offer hope to those who are affected by epilepsy. The neurological condition i…
US Oncology Research Affiliated Investigators Participated in Studies that … – MarketWatch (press release)
US Oncology Research Affiliated Investigators Participated in Studies that …MarketWatch (press release)"When we presented our data with the Syk inhibitor fostamatinib at the ASH plenary session in 2008, B Cell Receptor signaling inhibitors were …
Vitro Biopharma Introduces New Products for Personalized Cellular Medicine – MarketWatch (press release)
Vitro Biopharma Introduces New Products for Personalized Cellular MedicineMarketWatch (press release)… to study potential treatment of various conditions including, Type I & II diabetes, Parkinson's disease, organ transplant rejection, osteoa…
Talon Therapeutics Announces First Patient Enrolled in the Phase 3 OPTIMAL>60 … – MarketWatch (press release)
Talon Therapeutics Announces First Patient Enrolled in the Phase 3 OPTIMAL>60 …MarketWatch (press release)The title of the DSHNHL study is "Improvement of outcome and reduction in toxicity in elderly patients with CD20+ aggressive B-cell lymp…